2024-04-30 11:53:23 ET
More on United Therapeutics
- United Therapeutics: Neutral Stance On Tyvaso's Patent Challenges And Future Growth Prospects
- United Therapeutics Corporation (UTHR) Q4 2023 Earnings Call Transcript
- United Therapeutics Corporation 2023 Q4 - Results - Earnings Call Presentation
- Doctors perform first combined heart pump and pig kidney transplant surgery
- United Therapeutics motion for restraining order over Liquidia's Yutrepia denied
Read the full article on Seeking Alpha
For further details see:
United Therapeutics Q1 2024 Earnings Preview